Zobrazeno 1 - 8
of 8
pro vyhledávání: '"M. Y. Drokov"'
Autor:
M. Y. Drokov, T. V. Gaponova, T. Y. Gubenko, O. S. Karavaeva, M. A. Telyashov, A. S. Antimonov, V. V. Zubkov, E. N. Parovichnikova
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 23, Iss 2 (2023)
Despite their widespread clinical implementation, chimeric antigen receptor T-cell (CAR-T) therapy products, including those manufactured by industrial processes, are still not legally available or used in the Russian Federation.The aim of the study
Externí odkaz:
https://doaj.org/article/d7e8f7f98cc847dbb414672bcb4b8841
Autor:
E N PAROVICHNIKOVA, I A LOUKIANOVA, V V TROITSKAYA, M Y DROKOV, T I LOBAOVA, L A KUZMINA, A N SOKOLOV, A V KOKHNO, Z T FIDAROVA, G A BASKHAEVA, O A GAVRILINA, V A VASILYEVA, T N OBUKHOVA, S A KUZNETSOVA, A B SUDARIKOV, V N DVIRNIK, I V GALTSEVA, J O DAVIDIVA, S M KULIKOV, V G SAVCHENKO
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 14-22 (2018)
Objective. To analyze treatment results of 172 patients with acute myeloid leukemia (AML) aged 18-60 years in National Medical Research Center for Hematology of MHRF. Materials and methods. Inductive and consolidation program for 139 (80%) patients w
Externí odkaz:
https://doaj.org/article/86c14a4b80d349a59c1c8acc0003408d
Autor:
A. E. Shchekina, G. M. Galstyan, M. Y. Drokov, L. A. Kuzmina, E. N. Denisova, N. M. Arapova, V. V. Troitskaya, E. N. Parovichnikova
Publikováno v:
Russian journal of hematology and transfusiology. 67:308-327
Introduction. Life-threatening complications of allogeneic hematopoietic stem cell transplantation (allo-HSCT) can have a significant influence on the short-term and long-term prognosis in recipients of hematopoietic stem cells (allo-HSCs).Aim —
Publikováno v:
Russian journal of hematology and transfusiology. 67:216-239
Introduction. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is often complicated by life-threatening conditions.Aim — an analysis of the life-threatening complications in recipients of allogeneic hematopoietic stem cells (allo-HSCs
Autor:
S. V. Batryakova, I. T. Ibragimova, A. A. Dmitrova, M Y Drokov, A. P. Guzevatykh, V. A. Vasileva, Elena N. Parovichnikova, Larisa A. Kuzmina
Publikováno v:
Vrach i informacionnye tehnologii. :15-20
Autor:
O M Koroleva, E. Mikhaltsova, Larisa A. Kuzmina, M Y Drokov, Valeriy G. Savchenko, E V Usikova, V. A. Vasileva, Elena N. Parovichnikova, A. A. Dmitrova
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 13, Iss 1, Pp 89-94 (2019)
Aim. To assess the rehospitalization data of patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT), to determine possible risk factors for rehospitalization, and to work out a strategy of post-transplantation follow-up for thi
Autor:
Larisa P. Mendeleeva, NL Deineko, M V Solovev, Maya Firsova, Valeriy G. Savchenko, M Y Drokov, Alla M. Kovrigina
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 12, Iss 4, Pp 377-384 (2019)
Aim. To study immunohistochemical parameters of tumor plasma cells in bone marrow and to assess how the expression of adhesion molecule CD56 impacts overall survival (OS) of multiple myeloma (MM) patients. Materials & Methods. The trial included 35 p
Autor:
A S, Vdovin, S Y, Filkin, P R, Yefimova, S A, Sheetikov, N M, Kapranov, Y O, Davydova, E S, Egorov, E G, Khamaganova, M Y, Drokov, L A, Kuzmina, E N, Parovichnikova, G A, Efimov, V G, Savchenko
Publikováno v:
Biochemistry. Biokhimiia. 81(11)
Patients undergoing allogeneic hematopoietic stem cell transplantation have a high risk of cytomegalovirus reactivation, which in the absence of T-cell immunity can result in the development of an acute inflammatory reaction and damage of internal or